Shoshana Frankenburg

1.2k total citations
68 papers, 910 citations indexed

About

Shoshana Frankenburg is a scholar working on Public Health, Environmental and Occupational Health, Immunology and Epidemiology. According to data from OpenAlex, Shoshana Frankenburg has authored 68 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Public Health, Environmental and Occupational Health, 29 papers in Immunology and 15 papers in Epidemiology. Recurrent topics in Shoshana Frankenburg's work include Research on Leishmaniasis Studies (29 papers), Immunotherapy and Immune Responses (17 papers) and Trypanosoma species research and implications (12 papers). Shoshana Frankenburg is often cited by papers focused on Research on Leishmaniasis Studies (29 papers), Immunotherapy and Immune Responses (17 papers) and Trypanosoma species research and implications (12 papers). Shoshana Frankenburg collaborates with scholars based in Israel, United States and Canada. Shoshana Frankenburg's co-authors include Sidney N. Klaus, Michal Lotem, Tamar Peretz, Galit Eisenberg, Mauricio V. Londner, Vera Leibovici, Arthur Machlenkin, Daniel Vardy, Graciela Rosen and Sharon Merims and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Cancer Research.

In The Last Decade

Shoshana Frankenburg

66 papers receiving 882 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shoshana Frankenburg Israel 20 425 377 242 169 142 68 910
Fiona Greer United Kingdom 12 532 1.3× 143 0.4× 157 0.6× 404 2.4× 190 1.3× 17 1.1k
Muhammad M. Mukhtar Nigeria 16 279 0.7× 130 0.3× 203 0.8× 192 1.1× 204 1.4× 37 919
Alfredo Toraño Spain 16 310 0.7× 340 0.9× 261 1.1× 261 1.5× 52 0.4× 31 787
Sarat K. Dalai India 16 487 1.1× 129 0.3× 176 0.7× 221 1.3× 71 0.5× 45 948
Asher Maroof United Kingdom 25 957 2.3× 868 2.3× 667 2.8× 196 1.2× 87 0.6× 36 1.8k
Herbert Leonel de Matos Guedes Brazil 21 297 0.7× 536 1.4× 559 2.3× 204 1.2× 71 0.5× 77 1.1k
Robert Etges Switzerland 19 320 0.8× 1.1k 3.0× 846 3.5× 402 2.4× 74 0.5× 26 1.5k
Maria F. Lima United States 22 375 0.9× 510 1.4× 776 3.2× 346 2.0× 48 0.3× 52 1.2k
Saman Habib India 23 210 0.5× 389 1.0× 155 0.6× 676 4.0× 104 0.7× 65 1.2k
Mahreen Ameen United Kingdom 19 224 0.5× 168 0.4× 685 2.8× 158 0.9× 64 0.5× 48 1.4k

Countries citing papers authored by Shoshana Frankenburg

Since Specialization
Citations

This map shows the geographic impact of Shoshana Frankenburg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoshana Frankenburg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoshana Frankenburg more than expected).

Fields of papers citing papers by Shoshana Frankenburg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoshana Frankenburg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoshana Frankenburg. The network helps show where Shoshana Frankenburg may publish in the future.

Co-authorship network of co-authors of Shoshana Frankenburg

This figure shows the co-authorship network connecting the top 25 collaborators of Shoshana Frankenburg. A scholar is included among the top collaborators of Shoshana Frankenburg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoshana Frankenburg. Shoshana Frankenburg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stern, Otto, et al.. (2025). Alternative splicing of modulatory immune receptors in T lymphocytes: a newly identified and targetable mechanism for anticancer immunotherapy. Frontiers in Immunology. 15. 1490035–1490035. 2 indexed citations
2.
Schaft, Niels, Jan Dörrie, Gerold Schuler, et al.. (2023). The future of affordable cancer immunotherapy. Frontiers in Immunology. 14. 1248867–1248867. 38 indexed citations
3.
Weinstein‐Fudim, Liza, Shoshana Frankenburg, Tamar Peretz, et al.. (2023). Preventing skin toxicities induced by EGFR inhibitors by topically blocking drug-receptor interactions. Science Translational Medicine. 15(699). eabo0684–eabo0684.
4.
Hajaj, Emma, Sharon Merims, Jonathan Cohen, et al.. (2021). Alternative Splicing of the Inhibitory Immune Checkpoint Receptor SLAMF6 Generates a Dominant Positive Form, Boosting T-cell Effector Functions. Cancer Immunology Research. 9(6). 637–650. 14 indexed citations
5.
Hajaj, Emma, Galit Eisenberg, Shiri Klein, et al.. (2020). SLAMF6 deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint. eLife. 9. 26 indexed citations
6.
Eisenberg, Galit, Emma Hajaj, Sharon Merims, et al.. (2018). Soluble SLAMF6 Receptor Induces Strong CD8+ T-cell Effector Function and Improves Anti-Melanoma Activity In Vivo. Cancer Immunology Research. 6(2). 127–138. 19 indexed citations
7.
Eisenberg, Galit, Sharon Merims, Shoshana Frankenburg, et al.. (2015). Human T Cell Crosstalk Is Induced by Tumor Membrane Transfer. PLoS ONE. 10(2). e0118244–e0118244. 11 indexed citations
8.
Amer, Johnny, Shoshana Frankenburg, & Eitan Fibach. (2009). Apheresis Induces Oxidative Stress in Blood Cells. Therapeutic Apheresis and Dialysis. 14(2). 166–171. 6 indexed citations
9.
Frankenburg, Shoshana, Igor Grinberg, Jacob Pitcovski, et al.. (2007). Immunological activation following transcutaneous delivery of HR-gp100 protein. Vaccine. 25(23). 4564–4570. 15 indexed citations
10.
Hazra, Banasri, Jacob Golenser, Sharmistha Bhattacharyya, et al.. (2002). Inhibitory activity of diospyrin derivatives against Leishmania major parasites in vitro. Indian Journal of Pharmacology. 34(6). 422–427. 6 indexed citations
11.
Vardy, Daniel, et al.. (2001). Efficacious topical treatment for human cutaneous leishmaniasis with ethanolic lipid amphotericin B. Transactions of the Royal Society of Tropical Medicine and Hygiene. 95(2). 184–186. 27 indexed citations
12.
Frankenburg, Shoshana, Xin Wang, & Yoram Milner. (1998). Vitamin A Inhibits Cytokines Produced by Type 1 Lymphocytesin Vitro. Cellular Immunology. 185(1). 75–81. 17 indexed citations
13.
14.
Frankenburg, Shoshana, et al.. (1993). EFFECT OF TOPICAL PAROMOMYCIN ON CELL‐MEDIATED IMMUNITY DURING CUTANEOUS LEISHMANIASIS. International Journal of Dermatology. 32(1). 68–70. 6 indexed citations
15.
Prausnitz, Mark R., Alexander A. Kon, Vanu G. Bose, et al.. (1993). Methods forin VivoTissue Electroporation Using Surface Electrodes. Drug Delivery. 1(2). 125–131. 16 indexed citations
16.
Sliwa, Karen, et al.. (1992). Human cutaneous leishmaniasis: in-vitro parasite-mononuclear cell interactions in immune and naive individuals. Archives of Dermatological Research. 284(4). 209–211. 2 indexed citations
17.
Enk, Claes D., et al.. (1989). Delayed-type hypersensitivity and lymphocyte proliferation in response to Leishmania major infection in a group of children in Jericho. Transactions of the Royal Society of Tropical Medicine and Hygiene. 83(2). 189–192. 19 indexed citations
18.
Frankenburg, Shoshana, et al.. (1984). Cell-mediated immunity in rats injected with an antimalaria T-cell line. Cellular Immunology. 84(1). 14–21. 5 indexed citations
19.
Green, Manfred S., et al.. (1983). The cellular and humoral immune response in subjects vaccinated against cutaneous leishmaniasis using Leishmania tropica major promastigotes. Parasite Immunology. 5(4). 337–344. 10 indexed citations
20.
Gery, Igal, et al.. (1977). Potentiation of the T lymphocyte response to mitogens. Cellular Immunology. 28(2). 325–333. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026